Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001387131-10-000757
Filing Date
2010-07-20
Accepted
2010-07-19 18:55:59
Documents
6
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT adamis-10ka_0715.htm 10-K/A 1764119
2 302 CERTIFICATION OF CEO ex-31_1.htm EX-31.1 14928
3 302 CERTIFICATION OF CFO ex-31_2.htm EX-31.2 14813
4 906 CERTIFICATION OF CEO ex-32_1.htm EX-32.1 7170
5 906 CERTIFICATION OF CFO ex-32_2.htm EX-32.2 7420
6 adamis-10k_07130.jpg GRAPHIC 7376
  Complete submission text file 0001387131-10-000757.txt   1820455
Mailing Address 2658 DEL MAR HEIGHTS RD #555 DEL MAR CA 92014
Business Address 2658 DEL MAR HEIGHTS RD #555 DEL MAR CA 92014 (858) 401-3984
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K/A | Act: 34 | File No.: 000-26372 | Film No.: 10959278
SIC: 2834 Pharmaceutical Preparations